Private Banking|Professional Solutions|Investment Management|Investment Banking|About us
Van Lanschot Kempen Logo
  • Solutions
  • Sectors
  • Careers
May 2017
Issuer's Adviser
USD 115 million
Initial Public Offering on NASDAQ


argenx is a clinical stage biopharmaceutical company creating and developing differentiated therapeutic antibodies for the treatment of cancer and severe autoimmune diseases

  • Kempen & Co acted as adviser to the issuer in this transaction

Fully focused on your future

Private Banking

  • Offices
  • Entrepreneurs
  • Healthcare
  • Executives
  • Business professionals
  • Wealth management
  • Conditions
  • Private Banking - Belgium
  • Private Banking - Switzerland

Professional Solutions

Investment Management

Investment Banking

© Van Lanschot Kempen NV 2023
About us
Security and fraud awareness
Privacy & cookies